Search Results - "Birkeland, Kåre I"

Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of Cardiovascular Outcomes in New Users of Sodium-Glucose Cotransporter-2 Inhibitors) by Kosiborod, Mikhail, Cavender, Matthew A, Fu, Alex Z, Wilding, John P, Khunti, Kamlesh, Holl, Reinhard W, Norhammar, Anna, Birkeland, Kåre I, Jørgensen, Marit Eika, Thuresson, Marcus, Arya, Niki, Bodegård, Johan, Hammar, Niklas, Fenici, Peter

“…BACKGROUND:Reduction in cardiovascular death and hospitalization for heart failure (HHF) was recently reported with the sodium-glucose cotransporter-2…”
Get full text

The efficacy and safety of insulin degludec given in variable once-daily dosing intervals compared with insulin glargine and insulin degludec dosed at the same time daily: a 26-week, randomized, open-label, parallel-group, treat-to-target trial in individuals with type 2 diabetes by Meneghini, Luigi, Atkin, Stephen L, Gough, Stephen C L, Raz, Itamar, Blonde, Lawrence, Shestakova, Marina, Bain, Stephen, Johansen, Thue, Begtrup, Kamilla, Birkeland, Kåre I

“…The requirement to inject current basal insulin analogs at a fixed time each day may complicate adherence and compromise glycemic control. This trial evaluated…”
Get full text

Effects of Vitamin D Supplementation on Insulin Sensitivity and Insulin Secretion in Subjects With Type 2 Diabetes and Vitamin D Deficiency: A Randomized Controlled Trial by Gulseth, Hanne L, Wium, Cecilie, Angel, Kristin, Eriksen, Erik F, Birkeland, Kåre I

“…In observational studies, low vitamin D levels are associated with type 2 diabetes (T2D), impaired glucose metabolism, insulin sensitivity, and insulin…”
Get full text

Weight Loss, Cardiovascular Risk Factors, and Quality of Life After Gastric Bypass and Duodenal Switch: A Randomized Trial by SOVIK, Torgeir T, AASHEIM, Erlend T, TAHA, Osama, ENGSTRÖM, My, FAGERLAND, Morten W, BJÖRKMAN, Sofia, KRISTINSSON, Jon, BIRKELAND, Kare I, MALA, Tom, OLBERS, Torsten

“…Gastric bypass and duodenal switch are currently performed bariatric surgical procedures. Uncontrolled studies suggest that duodenal switch induces greater…”
Get full text

Dapagliflozin is associated with lower risk of cardiovascular events and all‐cause mortality in people with type 2 diabetes (CVD‐REAL Nordic) when compared with dipeptidyl peptidase‐4 inhibitor therapy: A multinational observational study by Persson, Frederik, Nyström, Thomas, Jørgensen, Marit E., Carstensen, Bendix, Gulseth, Hanne L., Thuresson, Marcus, Fenici, Peter, Nathanson, David, Eriksson, Jan W., Norhammar, Anna, Bodegard, Johan, Birkeland, Kåre I.

“…Aims To compare the sodium‐glucose‐cotransporter‐2 (SGLT‐2) inhibitor dapagliflozin with dipeptidyl peptidase‐4 (DPP‐4) inhibitors with regard to risk…”
Get full text

Cardiovascular mortality and morbidity in patients with type 2 diabetes following initiation of sodium-glucose co-transporter-2 inhibitors versus other glucose-lowering drugs (CVD-REAL Nordic): a multinational observational analysis by Birkeland, Kåre I, Jørgensen, Marit E, Carstensen, Bendix, Persson, Frederik, Gulseth, Hanne L, Thuresson, Marcus, Fenici, Peter, Nathanson, David, Nyström, Thomas, Eriksson, Jan W, Bodegård, Johan, Norhammar, Anna

“…In patients with type 2 diabetes and a high cardiovascular risk profile, the sodium-glucose co-transporter-2 (SGLT2) inhibitors empagliflozin and canagliflozin…”
Get full text

Cardiovascular and Renal Disease Burden in Type 1 Compared With Type 2 Diabetes: A Two-Country Nationwide Observational Study by Kristófi, Robin, Bodegard, Johan, Norhammar, Anna, Thuresson, Marcus, Nathanson, David, Nyström, Thomas, Birkeland, Kåre I, Eriksson, Jan W

“…Type 1 diabetes (T1D) and type 2 diabetes (T2D) increase risks of cardiovascular (CV) and renal disease (CVRD) compared with diabetes-free populations. Direct…”
Get full text

Five-year outcomes after laparoscopic gastric bypass and laparoscopic duodenal switch in patients with body mass index of 50 to 60: a randomized clinical trial by Risstad, Hilde, Søvik, Torgeir T, Engström, My, Aasheim, Erlend T, Fagerland, Morten W, Olsén, Monika Fagevik, Kristinsson, Jon A, le Roux, Carel W, Bøhmer, Thomas, Birkeland, Kåre I, Mala, Tom, Olbers, Torsten

“…There is no consensus as to which bariatric procedure is preferred to reduce weight and improve health in patients with a body mass index higher than 50. To…”
Get more information

Heart failure and chronic kidney disease manifestation and mortality risk associations in type 2 diabetes: A large multinational cohort study by Birkeland, Kåre I., Bodegard, Johan, Eriksson, Jan W., Norhammar, Anna, Haller, Hermann, Linssen, Gerard C.M., Banerjee, Amitava, Thuresson, Marcus, Okami, Suguru, Garal‐Pantaler, Elena, Overbeek, Jetty, Mamza, Jil Billy, Zhang, Ruiqi, Yajima, Toshitaka, Komuro, Issei, Kadowaki, Takashi

“…Aims To examine the manifestation of cardiovascular or renal disease (CVRD) in patients with type 2 diabetes (T2D) initially free from CVRD as well as the…”
Get full text

Evaluation of an interprofessional follow-up intervention among people with type 2 diabetes in primary care—A randomized controlled trial with embedded qualitative interviews by Graue, Marit, Igland, Jannicke, Haugstvedt, Anne, Hernar, Ingvild, Birkeland, Kåre I, Zoffmann, Vibeke, Richards, David A, Kolltveit, Beate-Christin Hope

“…With an ageing population and improved treatments people live longer with their chronic diseases, and primary care clinics face more costly and…”
Get full text

Fetuin A in nonalcoholic fatty liver disease: in vivo and in vitro studies by Haukeland, John Willy, Dahl, Tuva B, Yndestad, Arne, Gladhaug, Ivar P, Løberg, Else Marit, Haaland, Terese, Konopski, Zbigniew, Wium, Cecilie, Aasheim, Erlend T, Johansen, Odd Erik, Aukrust, Pål, Halvorsen, Bente, Birkeland, Kåre I

“…ObjectiveFetuin A has been associated with insulin resistance and the metabolic syndrome. We therefore explored the role of fetuin A in nonalcoholic fatty…”
Get full text

Fetal growth trajectories in pregnancies of European and South Asian mothers with and without gestational diabetes, a population-based cohort study by Sletner, Line, Jenum, Anne Karen, Yajnik, Chittaranjan S, Mørkrid, Kjersti, Nakstad, Britt, Rognerud-Jensen, Odd Harald, Birkeland, Kåre I, Vangen, Siri

“…Our aim was to examine the impact of gestational diabetes (GDM), from before the GDM-diagnosis is made, on fetal growth trajectories, and to compare it in…”
Get full text

Some Lessons Learned About Diabetes and COVID-19 During the Early Stage of the Epidemic in Norway by Birkeland, Kåre I.

Get full text

Branched-chain amino acid metabolism, insulin sensitivity and liver fat response to exercise training in sedentary dysglycaemic and normoglycaemic men by Lee, Sindre, Gulseth, Hanne L., Langleite, Torgrim M., Norheim, Frode, Olsen, Thomas, Refsum, Helga, Jensen, Jørgen, Birkeland, Kåre I., Drevon, Christian A.

“…Aims/hypothesis Obesity and insulin resistance may be associated with elevated plasma concentration of branched-chain amino acids (BCAAs) and impaired BCAA…”
Get full text

SGLT-2 Inhibitors and Cardiovascular Risk: An Analysis of CVD-REAL by Cavender, Matthew A, Norhammar, Anna, Birkeland, Kåre I, Jørgensen, Marit Eika, Wilding, John P, Khunti, Kamlesh, Fu, Alex Z, Bodegård, Johan, Blak, Betina T, Wittbrodt, Eric, Thuresson, Marcus, Fenici, Peter, Hammar, Niklas, Kosiborod, Mikhail

“…Prior studies found patients treated with sodium-glucose co-transporter-2 inhibitors (SGLT-2i) had lower rates of death and heart failure (HF). Whether the…”
Get full text

Are serum concentrations of vitamin B-12 causally related to cardiometabolic risk factors and disease? A Mendelian randomization study by Moen, Gunn-Helen, Qvigstad, Elisabeth, Birkeland, Kåre I, Evans, David M, Sommer, Christine

“…Several observational studies have shown that low serum vitamin B-12 is associated with increased body mass index (BMI) and adverse cardiometabolic outcomes…”
Get full text

Insulin Degludec in Type 1 Diabetes: A randomized controlled trial of a new-generation ultra-long-acting insulin compared with insulin glargine by BIRKELAND, Kare I, HOME, Philip D, MENEGHINI, Luigi F, WENDISCH, Ulrich, RATNER, Robert E, JOHANSEN, Thue, ENDAHL, Lars A, LYBY, Karsten, JENDLE, Johan H, ROBERTS, Anthony P, HANS DEVRIES, J

“…Insulin degludec (IDeg) is a basal insulin that forms soluble multihexamers after subcutaneous injection, resulting in an ultra-long action profile. We…”
Get full text

Intake of different types of seafood and meat and risk of type 2 diabetes in women: a prospective study supported by a dietary intervention in mice by Myrmel, Lene S., Øyen, Jannike, Brantsæter, Anne Lise, Fjære, Even, Haugvaldstad, Karen, Birkeland, Kåre I., Nygård, Ottar, Kristiansen, Karsten, Egeland, Grace M., Madsen, Lise

“…Detailed knowledge regarding the associations between intake of different types of seafood and meat and the risk of type 2 diabetes (T2D), and insight into…”
Get full text

Long-term diabetes complications after pancreas transplantation by Jenssen, Trond, Hartmann, Anders, Birkeland, Kåre I.

“…The intention of this study is to summarize present knowledge about adverse effects of hyperglycemia in diabetes, and in this context review more recent data…”
Get full text

Placental weight, surface area, shape and thickness - Relations with maternal ethnicity and cardio-metabolic factors during pregnancy by Sletner, Line, Yajnik, Chittaranjan S., Turowski, Gitta, Michelsen, Trond M., Sommer, Christine, Birkeland, Kåre I., Roald, Borghild, Jenum, Anne Karen

“…A better understanding of the determinants of placental growth is needed. Our primary aim was to explore associations between maternal ethnic origin and…”
Get full text